| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Fetal Growth Retardation | 26 | 2020 | 217 | 9.32 | Why? |
| Pregnancy, Twin | 21 | 2020 | 133 | 8.22 | Why? |
| Ultrasonography, Prenatal | 37 | 2020 | 471 | 6.30 | Why? |
| Hypertension, Pregnancy-Induced | 11 | 2020 | 208 | 6.23 | Why? |
| Pre-Eclampsia | 19 | 2021 | 599 | 4.50 | Why? |
| Twins, Monozygotic | 11 | 2020 | 83 | 4.18 | Why? |
| Infant, Small for Gestational Age | 10 | 2021 | 151 | 3.76 | Why? |
| Fetofetal Transfusion | 7 | 2020 | 24 | 3.64 | Why? |
| Middle Cerebral Artery | 8 | 2019 | 128 | 3.37 | Why? |
| Umbilical Arteries | 10 | 2019 | 62 | 3.23 | Why? |
| Pregnancy | 111 | 2021 | 23879 | 2.87 | Why? |
| Blood Pressure Monitoring, Ambulatory | 6 | 2019 | 341 | 2.65 | Why? |
| Placental Insufficiency | 5 | 2018 | 16 | 2.56 | Why? |
| Perinatal Mortality | 8 | 2020 | 120 | 2.50 | Why? |
| Prenatal Diagnosis | 8 | 2020 | 345 | 2.47 | Why? |
| Gestational Age | 27 | 2020 | 1488 | 2.17 | Why? |
| Diseases in Twins | 3 | 2020 | 86 | 2.16 | Why? |
| Fetal Distress | 3 | 2019 | 70 | 2.14 | Why? |
| Uterine Artery | 5 | 2020 | 36 | 2.07 | Why? |
| Fetal Weight | 5 | 2020 | 24 | 2.03 | Why? |
| Pregnancy Outcome | 28 | 2021 | 3803 | 2.01 | Why? |
| Birth Weight | 9 | 2020 | 250 | 1.98 | Why? |
| Ultrasonography, Doppler | 8 | 2019 | 406 | 1.76 | Why? |
| Pulsatile Flow | 11 | 2020 | 123 | 1.70 | Why? |
| Placentation | 3 | 2018 | 11 | 1.68 | Why? |
| Premature Birth | 13 | 2021 | 2151 | 1.63 | Why? |
| Pregnancy Complications, Infectious | 20 | 2021 | 11559 | 1.60 | Why? |
| Prenatal Care | 8 | 2020 | 1314 | 1.51 | Why? |
| Vascular Resistance | 3 | 2018 | 148 | 1.48 | Why? |
| Vascular Stiffness | 6 | 2020 | 264 | 1.33 | Why? |
| Stillbirth | 7 | 2021 | 544 | 1.31 | Why? |
| Placenta | 7 | 2021 | 1531 | 1.24 | Why? |
| Vascular Endothelial Growth Factor Receptor-1 | 2 | 2017 | 120 | 1.22 | Why? |
| Endpoint Determination | 4 | 2020 | 344 | 1.08 | Why? |
| Delphi Technique | 6 | 2020 | 1257 | 0.97 | Why? |
| Oxytocics | 2 | 2019 | 47 | 0.97 | Why? |
| Live Birth | 4 | 2020 | 200 | 0.95 | Why? |
| Infant, Newborn | 35 | 2021 | 23105 | 0.93 | Why? |
| Postpartum Hemorrhage | 2 | 2021 | 144 | 0.91 | Why? |
| Polycythemia | 1 | 2020 | 19 | 0.87 | Why? |
| Diabetes, Gestational | 4 | 2018 | 426 | 0.86 | Why? |
| Crown-Rump Length | 4 | 2019 | 22 | 0.85 | Why? |
| Counseling | 3 | 2021 | 747 | 0.83 | Why? |
| Fetus | 3 | 2018 | 484 | 0.81 | Why? |
| Cesarean Section | 8 | 2021 | 2089 | 0.81 | Why? |
| Placental Circulation | 2 | 2018 | 18 | 0.80 | Why? |
| Stroke Volume | 3 | 2018 | 2153 | 0.77 | Why? |
| Female | 112 | 2021 | 380317 | 0.76 | Why? |
| Placenta Growth Factor | 2 | 2017 | 93 | 0.76 | Why? |
| Fetal Development | 2 | 2017 | 173 | 0.75 | Why? |
| Hemodynamics | 6 | 2018 | 1562 | 0.74 | Why? |
| Obstetrical Forceps | 1 | 2017 | 5 | 0.73 | Why? |
| Cardiac Output, Low | 1 | 2017 | 31 | 0.72 | Why? |
| Twin Studies as Topic | 1 | 2017 | 9 | 0.71 | Why? |
| Twins | 1 | 2019 | 115 | 0.71 | Why? |
| Pregnancy Trimester, Third | 6 | 2018 | 445 | 0.71 | Why? |
| Body Height | 1 | 2018 | 100 | 0.69 | Why? |
| Intensive Care Units, Neonatal | 3 | 2021 | 749 | 0.64 | Why? |
| Tricuspid Valve Insufficiency | 1 | 2017 | 94 | 0.61 | Why? |
| Umbilical Cord | 1 | 2018 | 358 | 0.61 | Why? |
| Twins, Dizygotic | 2 | 2019 | 40 | 0.61 | Why? |
| Infectious Disease Transmission, Vertical | 9 | 2021 | 5164 | 0.61 | Why? |
| Adaptation, Physiological | 2 | 2018 | 359 | 0.59 | Why? |
| Placenta Accreta | 3 | 2020 | 24 | 0.58 | Why? |
| Fetal Diseases | 1 | 2017 | 182 | 0.57 | Why? |
| Research Design | 5 | 2020 | 5830 | 0.57 | Why? |
| Pregnancy Complications, Cardiovascular | 4 | 2018 | 231 | 0.56 | Why? |
| Perinatal Death | 6 | 2020 | 372 | 0.56 | Why? |
| Maternal Health Services | 2 | 2020 | 808 | 0.55 | Why? |
| Metformin | 2 | 2018 | 640 | 0.55 | Why? |
| Cytomegalovirus Infections | 2 | 2019 | 667 | 0.54 | Why? |
| Monitoring, Physiologic | 4 | 2019 | 1956 | 0.53 | Why? |
| Blood Flow Velocity | 3 | 2020 | 193 | 0.51 | Why? |
| Hypoxia | 2 | 2018 | 3626 | 0.51 | Why? |
| Anemia | 1 | 2020 | 789 | 0.50 | Why? |
| Humans | 113 | 2021 | 930598 | 0.46 | Why? |
| Body Weight | 1 | 2018 | 1074 | 0.46 | Why? |
| Vaccination Coverage | 1 | 2021 | 1249 | 0.46 | Why? |
| Placenta Previa | 3 | 2020 | 21 | 0.45 | Why? |
| Predictive Value of Tests | 11 | 2019 | 9537 | 0.44 | Why? |
| Case-Control Studies | 11 | 2021 | 17671 | 0.43 | Why? |
| Organizational Innovation | 1 | 2020 | 2468 | 0.41 | Why? |
| Blood Pressure | 5 | 2018 | 2198 | 0.40 | Why? |
| Hospitals, Maternity | 2 | 2021 | 154 | 0.40 | Why? |
| Cardiac Output | 4 | 2018 | 183 | 0.40 | Why? |
| Adult | 45 | 2021 | 244371 | 0.40 | Why? |
| Natriuretic Peptide, Brain | 1 | 2017 | 1215 | 0.40 | Why? |
| Obstetric Labor Complications | 2 | 2021 | 119 | 0.39 | Why? |
| Risk Assessment | 6 | 2020 | 25439 | 0.38 | Why? |
| Oxytocin | 2 | 2019 | 76 | 0.35 | Why? |
| Placenta Diseases | 2 | 2020 | 180 | 0.35 | Why? |
| Fetal Death | 3 | 2021 | 390 | 0.35 | Why? |
| Heart Defects, Congenital | 1 | 2017 | 933 | 0.34 | Why? |
| Influenza Vaccines | 2 | 2021 | 2941 | 0.34 | Why? |
| Pregnant Women | 5 | 2021 | 2535 | 0.33 | Why? |
| Obesity, Morbid | 1 | 2017 | 1340 | 0.32 | Why? |
| Pregnancy Complications | 1 | 2018 | 1388 | 0.32 | Why? |
| United Kingdom | 10 | 2021 | 18046 | 0.31 | Why? |
| Blood Pressure Determination | 3 | 2018 | 450 | 0.30 | Why? |
| Evidence-Based Medicine | 2 | 2018 | 3228 | 0.30 | Why? |
| Cost-Benefit Analysis | 3 | 2019 | 2259 | 0.28 | Why? |
| Clinical Decision-Making | 1 | 2019 | 3755 | 0.28 | Why? |
| Stakeholder Participation | 2 | 2019 | 481 | 0.28 | Why? |
| Patient Acceptance of Health Care | 2 | 2020 | 5002 | 0.28 | Why? |
| Pregnancy Trimesters | 3 | 2019 | 90 | 0.27 | Why? |
| Echocardiography | 2 | 2018 | 3661 | 0.27 | Why? |
| Epidemiologic Methods | 2 | 2017 | 392 | 0.26 | Why? |
| Prospective Studies | 15 | 2021 | 43301 | 0.26 | Why? |
| ROC Curve | 5 | 2019 | 6024 | 0.26 | Why? |
| Reference Standards | 2 | 2018 | 1163 | 0.26 | Why? |
| Abortion, Spontaneous | 2 | 2020 | 776 | 0.25 | Why? |
| London | 2 | 2020 | 2166 | 0.24 | Why? |
| Cohort Studies | 9 | 2021 | 36005 | 0.24 | Why? |
| Adverse Drug Reaction Reporting Systems | 2 | 2017 | 694 | 0.24 | Why? |
| Proportional Hazards Models | 3 | 2021 | 6543 | 0.24 | Why? |
| Perinatal Care | 2 | 2019 | 576 | 0.23 | Why? |
| Consensus Development Conferences as Topic | 2 | 2019 | 93 | 0.23 | Why? |
| Consensus | 5 | 2020 | 6345 | 0.23 | Why? |
| Patient Education as Topic | 2 | 2021 | 1476 | 0.22 | Why? |
| Reference Values | 3 | 2018 | 795 | 0.21 | Why? |
| Parity | 2 | 2018 | 122 | 0.21 | Why? |
| Obstetric Surgical Procedures | 1 | 2020 | 24 | 0.21 | Why? |
| Retrospective Studies | 16 | 2019 | 105322 | 0.21 | Why? |
| Caribbean Region | 1 | 2021 | 349 | 0.20 | Why? |
| Amniocentesis | 1 | 2019 | 25 | 0.20 | Why? |
| Models, Statistical | 1 | 2017 | 5312 | 0.20 | Why? |
| Extraction, Obstetrical | 1 | 2019 | 11 | 0.20 | Why? |
| Growth Charts | 1 | 2019 | 18 | 0.20 | Why? |
| Congenital Abnormalities | 1 | 2021 | 170 | 0.20 | Why? |
| Hemangioma | 1 | 2020 | 62 | 0.20 | Why? |
| Glyburide | 1 | 2018 | 17 | 0.20 | Why? |
| Pregnancy Complications, Neoplastic | 1 | 2020 | 79 | 0.19 | Why? |
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2018 | 12 | 0.19 | Why? |
| Agenesis of Corpus Callosum | 1 | 2018 | 10 | 0.19 | Why? |
| Lacerations | 1 | 2019 | 35 | 0.19 | Why? |
| Bayes Theorem | 2 | 2019 | 3237 | 0.19 | Why? |
| Fetal Membranes, Premature Rupture | 1 | 2020 | 122 | 0.19 | Why? |
| Alpha-Globulins | 1 | 2018 | 18 | 0.19 | Why? |
| Fetal Mortality | 1 | 2018 | 34 | 0.19 | Why? |
| White Coat Hypertension | 1 | 2018 | 24 | 0.19 | Why? |
| Pregnancy Reduction, Multifetal | 1 | 2018 | 5 | 0.19 | Why? |
| Inositol | 1 | 2018 | 28 | 0.19 | Why? |
| Viral Vaccines | 1 | 2020 | 7560 | 0.19 | Why? |
| Maternal-Child Health Services | 1 | 2020 | 124 | 0.19 | Why? |
| Ophthalmic Artery | 1 | 2018 | 16 | 0.19 | Why? |
| Chorion | 1 | 2017 | 4 | 0.19 | Why? |
| Global Health | 3 | 2021 | 13911 | 0.18 | Why? |
| Fetal Movement | 1 | 2018 | 10 | 0.18 | Why? |
| Plasma Substitutes | 1 | 2018 | 24 | 0.18 | Why? |
| Fetoscopy | 1 | 2018 | 31 | 0.18 | Why? |
| Heterotaxy Syndrome | 1 | 2018 | 18 | 0.18 | Why? |
| Pertussis Vaccine | 1 | 2019 | 89 | 0.18 | Why? |
| Labetalol | 1 | 2017 | 13 | 0.18 | Why? |
| Practice Guidelines as Topic | 6 | 2020 | 15421 | 0.18 | Why? |
| Heart Septal Defects, Ventricular | 1 | 2018 | 33 | 0.18 | Why? |
| Nifedipine | 1 | 2017 | 27 | 0.18 | Why? |
| Infant Mortality | 1 | 2020 | 268 | 0.18 | Why? |
| Nitric Oxide Donors | 1 | 2018 | 53 | 0.18 | Why? |
| Reproductive Health Services | 1 | 2021 | 222 | 0.18 | Why? |
| Polyhydramnios | 1 | 2017 | 5 | 0.18 | Why? |
| Age of Onset | 1 | 2020 | 557 | 0.18 | Why? |
| Term Birth | 1 | 2018 | 56 | 0.18 | Why? |
| Oligohydramnios | 1 | 2017 | 14 | 0.18 | Why? |
| Fibronectins | 1 | 2018 | 92 | 0.18 | Why? |
| Fetal Hypoxia | 1 | 2017 | 8 | 0.17 | Why? |
| Ultrasonography, Doppler, Color | 1 | 2018 | 107 | 0.17 | Why? |
| Sildenafil Citrate | 1 | 2017 | 66 | 0.17 | Why? |
| Obesity | 1 | 2018 | 7388 | 0.17 | Why? |
| Aorta | 2 | 2017 | 355 | 0.17 | Why? |
| Obstetric Labor, Premature | 1 | 2018 | 114 | 0.17 | Why? |
| Aortic Coarctation | 1 | 2016 | 21 | 0.17 | Why? |
| Myocardial Contraction | 1 | 2018 | 123 | 0.17 | Why? |
| Analgesia, Epidural | 1 | 2017 | 63 | 0.17 | Why? |
| Randomized Controlled Trials as Topic | 5 | 2019 | 10649 | 0.17 | Why? |
| Thymus Gland | 1 | 2017 | 126 | 0.16 | Why? |
| Influenza, Human | 2 | 2021 | 10779 | 0.16 | Why? |
| Vertebral Artery | 1 | 2017 | 52 | 0.16 | Why? |
| Phosphodiesterase 5 Inhibitors | 1 | 2017 | 104 | 0.16 | Why? |
| Vaccination | 5 | 2021 | 19050 | 0.16 | Why? |
| Parturition | 1 | 2021 | 514 | 0.16 | Why? |
| Acyclovir | 1 | 2017 | 154 | 0.16 | Why? |
| Labor, Induced | 1 | 2017 | 186 | 0.16 | Why? |
| Maternal Death | 1 | 2017 | 108 | 0.16 | Why? |
| State Medicine | 2 | 2020 | 2847 | 0.16 | Why? |
| Nepal | 1 | 2020 | 1004 | 0.15 | Why? |
| Reproducibility of Results | 5 | 2020 | 11304 | 0.15 | Why? |
| Arterial Pressure | 1 | 2017 | 208 | 0.15 | Why? |
| Amniotic Fluid | 1 | 2017 | 249 | 0.15 | Why? |
| Health Personnel | 3 | 2021 | 29646 | 0.15 | Why? |
| Ultrasonography, Doppler, Pulsed | 1 | 2014 | 5 | 0.15 | Why? |
| Valine | 1 | 2017 | 359 | 0.15 | Why? |
| Pregnancy Trimester, First | 1 | 2017 | 366 | 0.14 | Why? |
| Pregnancy Trimester, Second | 1 | 2016 | 314 | 0.14 | Why? |
| Office Visits | 1 | 2019 | 489 | 0.14 | Why? |
| Logistic Models | 2 | 2021 | 9089 | 0.14 | Why? |
| Longitudinal Studies | 3 | 2020 | 9893 | 0.13 | Why? |
| Risk Factors | 14 | 2020 | 71621 | 0.13 | Why? |
| Clinical Trials, Phase II as Topic | 1 | 2017 | 801 | 0.13 | Why? |
| Analysis of Variance | 1 | 2017 | 950 | 0.13 | Why? |
| Abdomen | 1 | 2017 | 424 | 0.13 | Why? |
| Propensity Score | 1 | 2021 | 2690 | 0.12 | Why? |
| Mobile Applications | 2 | 2019 | 3032 | 0.12 | Why? |
| Appointments and Schedules | 1 | 2020 | 1204 | 0.12 | Why? |
| Double-Blind Method | 3 | 2018 | 5988 | 0.12 | Why? |
| Cardiovascular Diseases | 1 | 2017 | 11497 | 0.11 | Why? |
| Cytomegalovirus | 1 | 2017 | 600 | 0.11 | Why? |
| Circadian Rhythm | 1 | 2017 | 607 | 0.11 | Why? |
| Immunoglobulins | 1 | 2017 | 811 | 0.11 | Why? |
| Sensitivity and Specificity | 6 | 2018 | 22971 | 0.11 | Why? |
| Incidence | 5 | 2020 | 25622 | 0.11 | Why? |
| Treatment Outcome | 7 | 2020 | 51732 | 0.11 | Why? |
| Data Collection | 2 | 2017 | 1769 | 0.11 | Why? |
| Pandemics | 9 | 2021 | 389249 | 0.11 | Why? |
| Health Care Surveys | 1 | 2020 | 2942 | 0.11 | Why? |
| Biomarkers | 4 | 2018 | 23361 | 0.10 | Why? |
| Clinical Trials as Topic | 2 | 2021 | 7330 | 0.10 | Why? |
| Cardiovascular System | 1 | 2018 | 750 | 0.10 | Why? |
| Age Factors | 3 | 2021 | 21039 | 0.10 | Why? |
| Ventricular Dysfunction, Left | 1 | 2018 | 993 | 0.10 | Why? |
| Feasibility Studies | 1 | 2019 | 3467 | 0.10 | Why? |
| Self Care | 1 | 2018 | 918 | 0.10 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.10 | Why? |
| Social Determinants of Health | 1 | 2021 | 1757 | 0.10 | Why? |
| Ventricular Function, Left | 1 | 2018 | 1555 | 0.09 | Why? |
| Vascular Surgical Procedures | 1 | 2018 | 882 | 0.09 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.09 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.09 | Why? |
| Patient Compliance | 1 | 2018 | 1468 | 0.09 | Why? |
| Home Care Services | 1 | 2019 | 1351 | 0.09 | Why? |
| Telemedicine | 1 | 2019 | 25032 | 0.09 | Why? |
| Mothers | 1 | 2018 | 1624 | 0.09 | Why? |
| Smartphone | 1 | 2019 | 1840 | 0.08 | Why? |
| Pulse Wave Analysis | 2 | 2018 | 221 | 0.08 | Why? |
| Early Diagnosis | 1 | 2016 | 2443 | 0.08 | Why? |
| England | 4 | 2019 | 5116 | 0.08 | Why? |
| Decision Making | 1 | 2021 | 3132 | 0.08 | Why? |
| Population Surveillance | 2 | 2020 | 4967 | 0.08 | Why? |
| Hypertension | 2 | 2018 | 8895 | 0.08 | Why? |
| Magnetic Resonance Imaging | 2 | 2020 | 6551 | 0.08 | Why? |
| Clinical Protocols | 1 | 2017 | 2734 | 0.08 | Why? |
| Remote Consultation | 1 | 2020 | 2396 | 0.07 | Why? |
| Risk | 1 | 2018 | 5288 | 0.07 | Why? |
| Hypoglycemic Agents | 1 | 2018 | 2165 | 0.07 | Why? |
| Zika Virus | 1 | 2017 | 1924 | 0.07 | Why? |
| Body Mass Index | 1 | 2018 | 4306 | 0.07 | Why? |
| Fever | 1 | 2021 | 7795 | 0.07 | Why? |
| Public Health Surveillance | 1 | 2017 | 3129 | 0.07 | Why? |
| Zika Virus Infection | 1 | 2017 | 1920 | 0.07 | Why? |
| Postpartum Period | 2 | 2020 | 936 | 0.06 | Why? |
| Communicable Diseases, Emerging | 1 | 2017 | 2523 | 0.06 | Why? |
| Young Adult | 5 | 2021 | 93724 | 0.06 | Why? |
| Algorithms | 1 | 2019 | 7346 | 0.06 | Why? |
| Triage | 1 | 2020 | 7151 | 0.05 | Why? |
| Hospitalization | 3 | 2020 | 54280 | 0.05 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.05 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 13720 | 0.05 | Why? |
| In Situ Hybridization, Fluorescence | 1 | 2021 | 207 | 0.05 | Why? |
| Hydrops Fetalis | 1 | 2020 | 33 | 0.05 | Why? |
| Episiotomy | 1 | 2019 | 10 | 0.05 | Why? |
| Observational Studies as Topic | 2 | 2018 | 1887 | 0.05 | Why? |
| Pelvic Floor | 1 | 2019 | 48 | 0.05 | Why? |
| Drug Monitoring | 2 | 2018 | 1408 | 0.05 | Why? |
| Length of Stay | 1 | 2018 | 11042 | 0.05 | Why? |
| Cervix Mucus | 1 | 2018 | 4 | 0.05 | Why? |
| Torsion, Mechanical | 1 | 2018 | 2 | 0.05 | Why? |
| Perineum | 1 | 2019 | 70 | 0.05 | Why? |
| Infant Health | 1 | 2020 | 160 | 0.05 | Why? |
| Fetal Monitoring | 1 | 2018 | 80 | 0.05 | Why? |
| Vitamin B Complex | 1 | 2018 | 49 | 0.05 | Why? |
| Uterus | 1 | 2018 | 98 | 0.05 | Why? |
| Prevalence | 2 | 2018 | 25773 | 0.05 | Why? |
| Glycemic Index | 1 | 2018 | 115 | 0.04 | Why? |
| Sri Lanka | 1 | 2018 | 241 | 0.04 | Why? |
| Intensive Care, Neonatal | 1 | 2020 | 284 | 0.04 | Why? |
| Uganda | 1 | 2021 | 1057 | 0.04 | Why? |
| Biomechanical Phenomena | 1 | 2018 | 291 | 0.04 | Why? |
| Observer Variation | 1 | 2020 | 622 | 0.04 | Why? |
| Administration, Cutaneous | 1 | 2018 | 229 | 0.04 | Why? |
| Biomedical Research | 1 | 2018 | 5270 | 0.04 | Why? |
| Whooping Cough | 1 | 2019 | 201 | 0.04 | Why? |
| Diagnostic Techniques, Cardiovascular | 1 | 2017 | 144 | 0.04 | Why? |
| Pilot Projects | 2 | 2018 | 5182 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Corpus Callosum | 1 | 2018 | 182 | 0.04 | Why? |
| Anal Canal | 1 | 2019 | 367 | 0.04 | Why? |
| Microcephaly | 1 | 2017 | 181 | 0.04 | Why? |
| Africa South of the Sahara | 1 | 2020 | 1335 | 0.04 | Why? |
| Women's Health | 1 | 2020 | 444 | 0.04 | Why? |
| Cerebrovascular Circulation | 1 | 2018 | 340 | 0.04 | Why? |
| Disease Outbreaks | 2 | 2020 | 27595 | 0.04 | Why? |
| Fertilization in Vitro | 1 | 2018 | 330 | 0.04 | Why? |
| Ventricular Function, Right | 1 | 2018 | 388 | 0.03 | Why? |
| Intensive Care Units | 1 | 2021 | 29594 | 0.03 | Why? |
| Multicenter Studies as Topic | 1 | 2021 | 2437 | 0.03 | Why? |
| Communicable Disease Control | 2 | 2021 | 29620 | 0.03 | Why? |
| Severity of Illness Index | 2 | 2020 | 48226 | 0.03 | Why? |
| Meta-Analysis as Topic | 1 | 2020 | 1289 | 0.03 | Why? |
| Infant | 3 | 2021 | 30274 | 0.03 | Why? |
| Cardiovascular Agents | 1 | 2018 | 663 | 0.03 | Why? |
| Ventricular Dysfunction, Right | 1 | 2018 | 639 | 0.03 | Why? |
| Delivery, Obstetric | 1 | 2019 | 1292 | 0.02 | Why? |
| Male | 3 | 2020 | 367725 | 0.02 | Why? |
| United States | 1 | 2017 | 46150 | 0.02 | Why? |
| Antiviral Agents | 2 | 2020 | 41703 | 0.02 | Why? |
| Heart Ventricles | 1 | 2016 | 1139 | 0.02 | Why? |
| Odds Ratio | 1 | 2018 | 5861 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2021 | 6740 | 0.02 | Why? |
| Dietary Supplements | 1 | 2018 | 2251 | 0.02 | Why? |
| Prognosis | 2 | 2020 | 32490 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2018 | 3444 | 0.02 | Why? |
| Antihypertensive Agents | 1 | 2017 | 1962 | 0.02 | Why? |
| Time Factors | 2 | 2019 | 31397 | 0.02 | Why? |
| Aged | 1 | 2020 | 215776 | 0.02 | Why? |
| Survival Rate | 1 | 2018 | 9206 | 0.02 | Why? |
| Middle Aged | 1 | 2020 | 270681 | 0.01 | Why? |
| Databases, Factual | 1 | 2016 | 6248 | 0.01 | Why? |
| Child | 2 | 2021 | 70012 | 0.01 | Why? |
| Brain | 1 | 2018 | 5133 | 0.01 | Why? |
| Spain | 1 | 2018 | 15545 | 0.01 | Why? |
| Mass Screening | 1 | 2019 | 8005 | 0.01 | Why? |
| Adolescent | 2 | 2019 | 86841 | 0.01 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2020 | 8843 | 0.01 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.01 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 8811 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2019 | 43792 | 0.01 | Why? |